Report Detail
Global Haemato Oncology Testing Market Growth (Status and Outlook) 2022-2028
- RnM4474102 |
- 27 July, 2022 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Medical Industry
The global market for Haemato Oncology Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Haemato Oncology Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Haemato Oncology Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Haemato Oncology Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Haemato Oncology Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Haemato Oncology Testing players cover Roche, Berry Genomics, Burning Rock Dx, BGI and Genetron, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Haemato Oncology Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Haemato Oncology Testing market, with both quantitative and qualitative data, to help readers understand how the Haemato Oncology Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Haemato Oncology Testing market and forecasts the market size by Type (Leukaemia, Lymphoma and Hodgkin Lymphoma), by Application (Clinical Laboratories, Hospitals, Academic and Research Institutes and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Leukaemia
Lymphoma
Hodgkin Lymphoma
Others
Segmentation by application
Clinical Laboratories
Hospitals
Academic and Research Institutes
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo
Chapter Introduction
Chapter 1: Scope of Haemato Oncology Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Haemato Oncology Testing market size and CAGR, Haemato Oncology Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Haemato Oncology Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Haemato Oncology Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Haemato Oncology Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, Haplox, Amoy Dx, Genosaber and YZY Biopharma and etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Haemato Oncology Testing Market Size 2017-2028
- 2.1.2 Haemato Oncology Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Haemato Oncology Testing Segment by Type
- 2.2.1 Leukaemia
- 2.2.2 Lymphoma
- 2.2.3 Hodgkin Lymphoma
- 2.2.4 Others
- 2.3 Haemato Oncology Testing Market Size by Type
- 2.3.1 Haemato Oncology Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Haemato Oncology Testing Market Size Market Share by Type (2017-2022)
- 2.4 Haemato Oncology Testing Segment by Application
- 2.4.1 Clinical Laboratories
- 2.4.2 Hospitals
- 2.4.3 Academic and Research Institutes
- 2.4.4 Others
- 2.5 Haemato Oncology Testing Market Size by Application
- 2.5.1 Haemato Oncology Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Haemato Oncology Testing Market Size Market Share by Application (2017-2022)
3 Haemato Oncology Testing Market Size by Player
- 3.1 Haemato Oncology Testing Market Size Market Share by Players
- 3.1.1 Global Haemato Oncology Testing Revenue by Players (2020-2022)
- 3.1.2 Global Haemato Oncology Testing Revenue Market Share by Players (2020-2022)
- 3.2 Global Haemato Oncology Testing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Haemato Oncology Testing by Regions
- 4.1 Haemato Oncology Testing Market Size by Regions (2017-2022)
- 4.2 Americas Haemato Oncology Testing Market Size Growth (2017-2022)
- 4.3 APAC Haemato Oncology Testing Market Size Growth (2017-2022)
- 4.4 Europe Haemato Oncology Testing Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Haemato Oncology Testing Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Haemato Oncology Testing Market Size by Country (2017-2022)
- 5.2 Americas Haemato Oncology Testing Market Size by Type (2017-2022)
- 5.3 Americas Haemato Oncology Testing Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Haemato Oncology Testing Market Size by Region (2017-2022)
- 6.2 APAC Haemato Oncology Testing Market Size by Type (2017-2022)
- 6.3 APAC Haemato Oncology Testing Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Haemato Oncology Testing by Country (2017-2022)
- 7.2 Europe Haemato Oncology Testing Market Size by Type (2017-2022)
- 7.3 Europe Haemato Oncology Testing Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Haemato Oncology Testing by Region (2017-2022)
- 8.2 Middle East & Africa Haemato Oncology Testing Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Haemato Oncology Testing Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Haemato Oncology Testing Market Forecast
- 10.1 Global Haemato Oncology Testing Forecast by Regions (2023-2028)
- 10.1.1 Global Haemato Oncology Testing Forecast by Regions (2023-2028)
- 10.1.2 Americas Haemato Oncology Testing Forecast
- 10.1.3 APAC Haemato Oncology Testing Forecast
- 10.1.4 Europe Haemato Oncology Testing Forecast
- 10.1.5 Middle East & Africa Haemato Oncology Testing Forecast
- 10.2 Americas Haemato Oncology Testing Forecast by Country (2023-2028)
- 10.2.1 United States Haemato Oncology Testing Market Forecast
- 10.2.2 Canada Haemato Oncology Testing Market Forecast
- 10.2.3 Mexico Haemato Oncology Testing Market Forecast
- 10.2.4 Brazil Haemato Oncology Testing Market Forecast
- 10.3 APAC Haemato Oncology Testing Forecast by Region (2023-2028)
- 10.3.1 China Haemato Oncology Testing Market Forecast
- 10.3.2 Japan Haemato Oncology Testing Market Forecast
- 10.3.3 Korea Haemato Oncology Testing Market Forecast
- 10.3.4 Southeast Asia Haemato Oncology Testing Market Forecast
- 10.3.5 India Haemato Oncology Testing Market Forecast
- 10.3.6 Australia Haemato Oncology Testing Market Forecast
- 10.4 Europe Haemato Oncology Testing Forecast by Country (2023-2028)
- 10.4.1 Germany Haemato Oncology Testing Market Forecast
- 10.4.2 France Haemato Oncology Testing Market Forecast
- 10.4.3 UK Haemato Oncology Testing Market Forecast
- 10.4.4 Italy Haemato Oncology Testing Market Forecast
- 10.4.5 Russia Haemato Oncology Testing Market Forecast
- 10.5 Middle East & Africa Haemato Oncology Testing Forecast by Region (2023-2028)
- 10.5.1 Egypt Haemato Oncology Testing Market Forecast
- 10.5.2 South Africa Haemato Oncology Testing Market Forecast
- 10.5.3 Israel Haemato Oncology Testing Market Forecast
- 10.5.4 Turkey Haemato Oncology Testing Market Forecast
- 10.5.5 GCC Countries Haemato Oncology Testing Market Forecast
- 10.6 Global Haemato Oncology Testing Forecast by Type (2023-2028)
- 10.7 Global Haemato Oncology Testing Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Roche Company Information
- 11.1.2 Roche Haemato Oncology Testing Product Offered
- 11.1.3 Roche Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Roche Main Business Overview
- 11.1.5 Roche Latest Developments
- 11.2 Berry Genomics
- 11.2.1 Berry Genomics Company Information
- 11.2.2 Berry Genomics Haemato Oncology Testing Product Offered
- 11.2.3 Berry Genomics Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Berry Genomics Main Business Overview
- 11.2.5 Berry Genomics Latest Developments
- 11.3 Burning Rock Dx
- 11.3.1 Burning Rock Dx Company Information
- 11.3.2 Burning Rock Dx Haemato Oncology Testing Product Offered
- 11.3.3 Burning Rock Dx Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Burning Rock Dx Main Business Overview
- 11.3.5 Burning Rock Dx Latest Developments
- 11.4 BGI
- 11.4.1 BGI Company Information
- 11.4.2 BGI Haemato Oncology Testing Product Offered
- 11.4.3 BGI Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 BGI Main Business Overview
- 11.4.5 BGI Latest Developments
- 11.5 Genetron
- 11.5.1 Genetron Company Information
- 11.5.2 Genetron Haemato Oncology Testing Product Offered
- 11.5.3 Genetron Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Genetron Main Business Overview
- 11.5.5 Genetron Latest Developments
- 11.6 Haplox
- 11.6.1 Haplox Company Information
- 11.6.2 Haplox Haemato Oncology Testing Product Offered
- 11.6.3 Haplox Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Haplox Main Business Overview
- 11.6.5 Haplox Latest Developments
- 11.7 Amoy Dx
- 11.7.1 Amoy Dx Company Information
- 11.7.2 Amoy Dx Haemato Oncology Testing Product Offered
- 11.7.3 Amoy Dx Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Amoy Dx Main Business Overview
- 11.7.5 Amoy Dx Latest Developments
- 11.8 Genosaber
- 11.8.1 Genosaber Company Information
- 11.8.2 Genosaber Haemato Oncology Testing Product Offered
- 11.8.3 Genosaber Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Genosaber Main Business Overview
- 11.8.5 Genosaber Latest Developments
- 11.9 YZY Biopharma
- 11.9.1 YZY Biopharma Company Information
- 11.9.2 YZY Biopharma Haemato Oncology Testing Product Offered
- 11.9.3 YZY Biopharma Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 YZY Biopharma Main Business Overview
- 11.9.5 YZY Biopharma Latest Developments
- 11.10 Wondfo
- 11.10.1 Wondfo Company Information
- 11.10.2 Wondfo Haemato Oncology Testing Product Offered
- 11.10.3 Wondfo Haemato Oncology Testing Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Wondfo Main Business Overview
- 11.10.5 Wondfo Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Haemato Oncology Testing. Industry analysis & Market Report on Haemato Oncology Testing is a syndicated market report, published as Global Haemato Oncology Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Haemato Oncology Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
